Avoro Capital Advisors LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Arrowhead Pharmaceuticals, Inc. (ARWR)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: Arrowhead Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol: ARWR
Shares outstanding: 125M shares
Disclosed Ownership: 12M shares
Ownership: 9.6%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 09:31 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	9.6%	12M	12M	0	/s/ Scott Epstein	Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh	9.6%	12M	12M	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually